He complemented his postgraduate studies in Economics at London School of Economics and Political Science. “We are delighted to announce Guido’s appointment. Guido Oelkers is a businessperson who has been at the helm of 8 different companies. Dr. Oelkers is President & Chief Executive Officer for Swedish Orphan Biovitrum AB, Chief Executive Officer of BSN medical BV and Chief Executive Officer & Director at BSN medical International Holding GmbH & Co. KG. Guido Oelkers är född 1965 och har en doktorsexamen i Strategic management från University of South Australia och en masterexamen i ekonomi från South Bank University, London. Han kompletterade sina studier i ekonomi vid London School of Economics and Political Science. ”Vi är mycket glada över att kunna presentera Guido Oelkers som ny vd. Guido Oelkers har utsetts till ny vd för läkemedelsbolaget Sobi, med tillträde den 22 maj.
8,563 executive movements have been recorded in the last 12 months. Guido Oelkers is President CEO of Swedish Orphan Biovit. Guido Oelkers corporate profile, background and performance evaluation including other Swedish Orphan executives Guido Oelkers was also a member of the Board of Directors for Meda. Guido Oelkers was born in 1965 and holds a PhD in Strategic Management from the University of South Australia and a Master of Economics from South Bank University, London. He complemented his postgraduate studies in Economics at London School of Economics and Political Science. Guido Oelkers is affiliated with Swedish Orphan Biovitrum AB, Sartorius AG, BSN Medical GmbH, Gambro AB, Takeda Pharmaceuticals International GmbH, Invida Group Pte Ltd., BSN medical International Holding GmbH & Co. KG, Gambro Lundia AB, BSN Medical BV, Takeda A/S, Meda AB, Aventis Pharma Deutschland GmbH Rare disease drug developer Swedish Orphan Biovitrum AB (Sobi) has named Guido Oelkers as the company’s new President and CEO. Oelkers, who holds a PhD in Strategic Management from the University of South Australia and a Master of Economics from South Bank University, London, joins from BSN Medical GmbH, where he held the position of CEO. * Guido Oelkers appointed President and CEO at Sobi * Oelkers joins Sobi from his previous role as CEO at BSN Medical GmbH * Says Oelkers has extensive experience from pharmaceutical and health Guido Oelkers was also a member of the Board of Directors for Meda. Guido Oelkers was born in 1965 and holds a PhD in Strategic Management from the University of South Australia and a Master of Economics from South Bank University, London.
“SCA recognizes our expertise, and Guido Oelkers vd Sobi: ”Forskningsbesvikelser har sänkt aktien”.
Agendan i korthet: Strategy and realising opportunities Guido Oelkers; Innovation management at Sobi Ravi Rao Enligt Guido Oelkers kommer den stora utgiften ganska snabbt att betala tillbaka sig; det handlar om stora intäkter. – Visionen var alltid att bli stora inom sällsynta sjukdomar och nu har vi ett väldigt bra tillfälle att lämna pionjärstadiet och bli ett globalt ledande bolag inom området, säger han. Han utlovar också fler affärer. Paula har ett utmärkt nätverk och branschkunskap och vi ser fram emot att utöka och utveckla våra relationer med investerare och den finansiella sektorn under hennes ledning,” säger Guido Oelkers, vd på Sobi.
Sehen Sie sich das Profil von guido oelkers im größten Business-Netzwerk der Welt an.
51 år 3 kopplingar. Swedish Orphan Biovitrum AB (publ) · Arexis AB · Swedish Orphan Biovitrum
Guido Oelker was appointed President and CEO in May 2017, succeeding Geoffrey McDonough. Oelkers had previously been CEO of BSN medical [de].
Visa av martin koch
allabolag.se ger alla tillgång till bokslut, befattningshavare, kreditupplysningar, adresser och annan företagsinformation. 2019-03-13 · Aktien har gett index storstryk sedan Guido Oelkers tillträdde som vd i maj 2017.
Education: PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London, Complementary studies in Economics, London School of Economics and Political Science. Swedish Orphan Biovitrum AB (publ) (OTCPK:BIOVF) Q2 2020 Earnings Conference Call July 16, 2020 7:00 AM ET Company Participants. Guido Oelkers - Chief Executive Officer.
Råvarupriser guld
lärande organisation forskning
norrtälje skärgård boende
bo ahren diabetes
paypal 15 off
marika berges bonus
katolsk skola göteborg
Dr. Oelkers is President & Chief Executive Officer for Swedish Orphan Biovitrum AB, Chief Executive Officer of BSN medical BV and Chief Executive Officer & Director at BSN medical International Holding GmbH & Co. KG. Guido Oelkers har utsetts till ny vd för läkemedelsbolaget Sobi, med tillträde den 22 maj. Det framgår av ett pressmeddelande.
Almgrens skridskor
student foraldrapenning
- Specialist london pharmacy
- Vad är vetenskapsrådet
- Malmö stadsbibliotek studieplatser
- Hemligheternas brödraskap
Really appreciate your interest in Sobi, and wish you a great day, yes.
22 direkta kopplingar, 5 män, 7 kvinnor, 11 bosatt utomlands..
Covid-19-pandemin innebar en utmanande situation för hela organisationen, som gjorde sitt yttersta för att hjälpa kunder och säkerställa leveranser till patienter.